Skip to main content
. 2016 Oct 28;7(48):79761–79773. doi: 10.18632/oncotarget.12962

Figure 5. VOSL suppressed the EGFR/MEK/P38 and EGFR/PI3-K/Akt pathways in HCC cells.

Figure 5

A and B. HCC cells were treated with Cos, Dehy, C+2D or VOSL at concentrations of 0, IC30 and IC50 for 48h, and then the expression levels of the relevant factors (P38, p-P38, Akt, p-Akt, ERK, p-ERK, EGFR and p-EGFR) were determined by Western blot.